These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11950960)

  • 1. CD40 activation in epithelial ovarian carcinoma cells modulates growth, apoptosis, and cytokine secretion.
    Gallagher NJ; Eliopoulos AG; Agathangelo A; Oates J; Crocker J; Young LS
    Mol Pathol; 2002 Apr; 55(2):110-20. PubMed ID: 11950960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential induction of nuclear factor-kappaB and activator protein-1 activity after CD40 ligation is associated with primary human hepatocyte apoptosis or intrahepatic endothelial cell proliferation.
    Ahmed-Choudhury J; Russell CL; Randhawa S; Young LS; Adams DH; Afford SC
    Mol Biol Cell; 2003 Apr; 14(4):1334-45. PubMed ID: 12686591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p38 mitogen-activated protein kinase and nuclear factor-κB facilitate CD40-mediated salivary epithelial cell death.
    Ping L; Ogawa N; Zhang Y; Sugai S; Masaki Y; Weiguo X
    J Rheumatol; 2012 Jun; 39(6):1256-64. PubMed ID: 22505709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of CD40 binding on ovarian carcinoma cell growth and cytokine production in vitro.
    Toutirais O; Gervais A; Cabillic F; Le Gallo M; Coudrais A; Levêque J; Catros-Quemener V; Genetet N
    Clin Exp Immunol; 2007 Aug; 149(2):372-7. PubMed ID: 17565609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of CD40 in cervical carcinoma cells facilitates CTL responses and augments chemotherapy-induced apoptosis.
    Hill SC; Youde SJ; Man S; Teale GR; Baxendale AJ; Hislop A; Davies CC; Luesley DM; Blom AM; Rickinson AB; Young LS; Eliopoulos AG
    J Immunol; 2005 Jan; 174(1):41-50. PubMed ID: 15611226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
    Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
    Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptor-associated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways.
    Pearson LL; Castle BE; Kehry MR
    Int Immunol; 2001 Mar; 13(3):273-83. PubMed ID: 11222496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40 expression on human pancreatic duct cells: role in nuclear factor-kappa B activation and production of pro-inflammatory cytokines.
    Vosters O; Beuneu C; Nagy N; Movahedi B; Aksoy E; Salmon I; Pipeleers D; Goldman M; Verhasselt V
    Diabetologia; 2004 Apr; 47(4):660-8. PubMed ID: 15298343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells.
    Schwabe RF; Schnabl B; Kweon YO; Brenner DA
    J Immunol; 2001 Jun; 166(11):6812-9. PubMed ID: 11359840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis.
    Harigai M; Hara M; Kawamoto M; Kawaguchi Y; Sugiura T; Tanaka M; Nakagawa M; Ichida H; Takagi K; Higami-Ohsako S; Shimada K; Kamatani N
    Arthritis Rheum; 2004 Jul; 50(7):2167-77. PubMed ID: 15248214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular responses to murine CD40 in a mouse B cell line may be TRAF dependent or independent.
    Manning E; Pullen SS; Souza DJ; Kehry M; Noelle RJ
    Eur J Immunol; 2002 Jan; 32(1):39-49. PubMed ID: 11754002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CD40 and growth-inhibitory activity of CD40 agonist in ovarian carcinoma cells.
    Zhou Y; He J; Gou LT; Mu B; Liao WC; Ma C; Tang P; Zhou SJ; Zhou YJ; Yang JL
    Cancer Immunol Immunother; 2012 Oct; 61(10):1735-43. PubMed ID: 22406982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD40 and growth-inhibitory activity of CD40 ligand in ovarian cancer cell lines.
    Melichar B; Patenia R; Gallardo S; Melicharová K; Hu W; Freedman RS
    Gynecol Oncol; 2007 Mar; 104(3):707-13. PubMed ID: 17166566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jun N-terminal kinase is essential for CD40-mediated IgE class switching in B cells.
    Jabara HH; Geha RS
    J Allergy Clin Immunol; 2005 Apr; 115(4):856-63. PubMed ID: 15806010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40 induces interleukin-6 gene transcription in dendritic cells: regulation by TRAF2, AP-1, NF-kappa B, AND CBF1.
    Mann J; Oakley F; Johnson PW; Mann DA
    J Biol Chem; 2002 May; 277(19):17125-38. PubMed ID: 11886848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible CD40 expression mediates NFkappaB activation and cytokine secretion in human colonic fibroblasts.
    Gelbmann CM; Leeb SN; Vogl D; Maendel M; Herfarth H; Schölmerich J; Falk W; Rogler G
    Gut; 2003 Oct; 52(10):1448-56. PubMed ID: 12970138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of tumor necrosis factor-alpha expression by CD40 ligation in BV-2 microglial cells.
    Jana M; Dasgupta S; Liu X; Pahan K
    J Neurochem; 2002 Jan; 80(1):197-206. PubMed ID: 11796758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis.
    Mineva ND; Rothstein TL; Meyers JA; Lerner A; Sonenshein GE
    J Biol Chem; 2007 Jun; 282(24):17475-85. PubMed ID: 17446175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-kappa B does not modulate sensitivity of renal carcinoma cells to TNF alpha-related apoptosis-inducing ligand (TRAIL).
    Pawlowski JE; Nesterov A; Scheinman RI; Johnson TR; Kraft AS
    Anticancer Res; 2000; 20(6B):4243-55. PubMed ID: 11205254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
    Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
    Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.